Sort   by:  
 Page size 
TranscriptomicsAffymetrix SNP array data for acute lymphoblastic leukemia and lymphoblastic lymphoma samples
Childhood T-cell malignancies include T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL). T-ALL and T-LBL share common morphologic and immunophenotypic features and are treated with similar therapeutic approaches. Nonetheless, they show distinct clinical presenta...
ORGANISM(S): Homo sapiens 
2012-06-29 | E-GEOD-30319 | biostudies-arrayexpress
GenomicsGenetic characterization of T-LBL
Morphological and genetic study of T-LBL
PRJEB43750 | ENA
GenomicsMolecular characterization of T-LBL
Molecular characterization of T-cell lymphoblastic lymphoma in children and adolescents reveals candidates of clinical relevance
PRJEB36436 | ENA
UnknownRuxolitinib as a Novel Therapeutic Option for Poor Prognosis T-LBL Pediatric Patients.
Not available
S-EPMC8345121 | biostudies-literature
UnknownHypomorphic mTOR Downregulates CDK6 and Delays Thymic Pre-T LBL Tumorigenesis.
Not available
S-EPMC9574474 | biostudies-literature
UnknownBPTF-665aa mediate chromatin remodeling drives chemoresistance in T-LBL/ALL.
Not available
S-EPMC12595860 | biostudies-literature
UnknownPIM1 is a potential therapeutic target for the leukemogenic effects mediated by JAK/STAT pathway mutations in T-ALL/LBL.
Not available
S-EPMC11271448 | biostudies-literature
Transcriptomicsgene expression analyses of pediatric lymphoblastic lymphomas and leukemias
T-cell acute lymphoblastic leukemia (T-ALL) and lymphoma (T-LBL) share common morphologic and immunophenotypic features and are treated with similar therapeutic approaches. Nonetheless, they show distinct clinical presentations suggesting that they may represent two different biological entities. In...
ORGANISM(S): Homo sapiens 
2012-05-31 | E-GEOD-29986 | biostudies-arrayexpress
UnknownNovel anti-LAG-3 antibody LBL-007 with anti-PD-1 blockade enhances antitumor immunity by promoting T cell-induced apoptosis.
Not available
S-EPMC12559405 | biostudies-literature
UnknownTBI/Cy followed by auto-HSCT is a good choice next to allo-HSCT for patients with T-LBL/ALL.
Not available
S-EPMC11437004 | biostudies-literature
Sort   by:  
 Page size